Safe Switch to an Oral Two‐Drug Regimen Based on Dolutegravir in People With Vertically Acquired HIV‐1: An Observational Multicenter Study

ABSTRACT Background and Aims People with vertically acquired HIV‐1 are exposed to antiretroviral drugs throughout their lives. Two‐drug regimens based on dolutegravir (DTG) are increasingly popular, showing excellent safety and efficacy and giving the opportunity to reduce toxicity and drug burden....

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Health science reports Ročník 8; číslo 7; s. e71047 - n/a
Hlavní autori:	Meraviglia, Giulia, Sala, Anna, Bassani, Francesco, Labate, Laura, Pagani, Gabriele, Giacomet, Vania, Di Biagio, Antonio, Rusconi, Stefano
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States John Wiley & Sons, Inc 01.07.2025 John Wiley and Sons Inc Wiley
Predmet:	Antiretroviral drugs Cholesterol dolutegravir Drug dosages Drug interactions Drug resistance Drug therapy Environmental Health High density lipoprotein HIV Human immunodeficiency virus Infections Infectious Diseases Low density lipoprotein Lymphocytes Mutation Obstetrics/Gynecology Paediatrics and Adolescent Medicine Protease inhibitors Research Communication Toxicity treatment‐experienced Triglycerides two‐drug regimen vertical HIV treatment‐experienced dolutegravir drug resistance vertical HIV two‐drug regimen
ISSN:	2398-8835, 2398-8835
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!